Ep. 106 - China's C-suite Hears FDA, Plus AACR, ARPA-H
BioCentury This Week
00:00
Can Chinese Companies Disrupt Pricing in the United States?
The question i would have semon is, what impact is this going to have on the ability of chinese comp s to disrupt pricing in the united states? There'd been some hope, in fact, doctor pastor had expressed that at the a a c r meeting in 20 19. But like you say, they're going to have to do more trials that are going to be more expensive. And i don't know how much wiggle room they've got.
Transcript
Play full episode
